Virtus ETF Advisers’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198K Sell
4,181
-6,143
-60% -$316K 0.08% 285
2026
Q1
$612K Hold
10,324
0.28% 93
2025
Q4
$637K Hold
10,324
0.3% 79
2025
Q3
$644K Hold
10,324
0.35% 74
2025
Q2
$824K Hold
10,324
0.5% 51
2025
Q1
$888K Buy
+10,324
New +$847K 0.58% 37

Other funds holding PBH

Virtus ETF Advisers's PBH Position: Q2 2026 in Review

Virtus ETF Advisers reduced its Prestige Consumer Healthcare (PBH) stake by 60% in Q2 2026, selling an estimated $316K and leaving 4,181 shares worth $198K. The position accounts for 0.08% of the portfolio, ranked #285.

Virtus ETF Advisers first reported a position in PBH in Q1 2025 and has held it in 6 quarters since. The position peaked at $888K in Q1 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Virtus ETF Advisers held 4,181 shares of Prestige Consumer Healthcare worth $198K as of Q2 2026.
  • Virtus ETF Advisers sold 6,143 Prestige Consumer Healthcare shares in Q2 2026, an estimated $316K.
  • Prestige Consumer Healthcare made up 0.08% of Virtus ETF Advisers's portfolio in Q2 2026, its #285 holding.
  • Virtus ETF Advisers first reported a position in Prestige Consumer Healthcare in Q1 2025 and has held it in 6 quarters since.
  • Virtus ETF Advisers's Prestige Consumer Healthcare position peaked at $888K in Q1 2025.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.